Supplements and Blood Tests: Biotin, Results, and Safety

By /

A blood test is useful only when the result can be interpreted correctly. The supplements you take can matter, even when you feel well and the product seems unrelated to the test. Biotin, a vitamin commonly included in hair, skin, and nail products, deserves particular attention because it can disrupt the measurement process in certain laboratory tests.

Health Canada warns that high amounts of biotin can produce falsely high or falsely low results in susceptible tests, including some thyroid and troponin tests. The consequence can be an incorrect diagnosis or an inappropriate treatment decision. The risk depends on the test and the exposure; taking a supplement does not automatically invalidate all your blood work. [1]

This guide explains what is known about supplements and blood tests, how biotin differs from nutrients that genuinely change your biology, and what information helps your clinician and laboratory protect the usefulness of a result.

If you have chest pain or other symptoms that could indicate a heart attack, call 911 in Canada or seek emergency care immediately. Tell the treating team about biotin use. Do not wait at home for biotin to clear before getting help.

In this article

Two different reasons a supplement can change a result

The first distinction is between a change in the body and a change in the measuring system. Both can produce a different number on a report, but they call for different responses.

  • A physiological effect: a nutrient changes the substance being measured or changes a biological process. Treatment for a deficiency can change subsequent laboratory findings. Those changes may be expected and clinically useful.
  • Analytical interference: something in the sample disrupts the test’s chemistry. The reported value may differ from the true concentration. Biotin interference is an example.

A third issue is context: a result obtained after treatment has started may answer a different question from a result obtained before treatment. A follow-up measurement can help assess treatment, yet may be less helpful for reconstructing the untreated baseline. These distinctions become especially relevant when discussing iron and vitamin B12. [11] [12]

Think of measuring the amount of water in a tank. Adding water changes what is in the tank; damaging the gauge changes what the instrument reports. A sensible investigation asks which process could explain the reading before deciding what to do next.

A systems biology view of biotin

Biotin, also called vitamin B7, helps enzymes handle glucose, fats, and amino acids. These pathways operate together: an essential nutrient does not necessarily provide extra benefit far beyond nutritional requirements. Deficiency is uncommon, and evidence for improving hair or nails without a relevant deficiency is limited. [2]

Biotin’s role in a laboratory instrument is separate from its nutritional role. Some tests use a very strong bond between biotin and a protein called streptavidin to hold parts of the test reaction together. Extra biotin carried into the test with a patient’s sample can compete for those binding sites. This competition can prevent the instrument from generating the signal expected from the substance being measured. [3] [10]

This is a useful example of how biology and measurement meet. The same molecule can support normal cellular chemistry inside the body and create a misleading signal in a particular testing method. Understanding the connection helps explain why a supplement history belongs beside the symptoms, medications, and laboratory report.

Why interference can raise one number and lower another

Laboratories use different test designs. In susceptible “sandwich” immunoassays, excess biotin generally makes the reported concentration lower. In susceptible competitive immunoassays, it generally makes the reported concentration higher. The direction comes from how the instrument converts its signal into a concentration. These principles describe test designs, not a universal rule for every test measuring a given hormone or protein. [3]

A low result on one test and a high result on another can therefore arise from the same interference. A seemingly consistent pattern does not prove the numbers are accurate. Equally, an unexpected result does not prove interference: real illness and analytical interference can coexist.

For patients, the useful question is not “Does this laboratory use biotin anywhere?” It is “Is the exact method being used for my requested test susceptible at the exposure I may have?” The laboratory can investigate the relevant method. A patient cannot reliably identify it from the test name alone.

What human studies actually show

A small study demonstrated that some assays were affected and others were not

In a 2017 JAMA study, six healthy adults took 10 mg of biotin daily for one week. Researchers examined 37 immunoassays measuring 11 substances. Interference occurred in nine of the 23 assays using biotin technology and in none of the 14 assays without that technology. The affected group included both falsely increased and falsely decreased measurements. [4]

The study offers direct evidence that a supplement can change reported results without causing the corresponding biological change. However, six participants cannot establish how often patients are harmed in routine practice. The findings also describe the methods studied at that time, rather than every current version of those tests.

Thyroid measurements showed differences between methods

A 2021 prospective study gave 13 adults 10 mg of biotin daily for eight days. Measurements were compared across several methods. Specific thyroid measurements changed with one platform, and thyroglobulin was falsely reduced with another. The greatest interference at the sampling times studied occurred two hours after taking biotin. [5]

This was an assay comparison, not a trial showing that biotin caused thyroid disease. It also did not establish a safe interval for all patients. The participants, dose, collection times, and selected methods define the study’s limits.

Timing depended on dose and assay

Another study recruited ten healthy adults and examined thyroid testing after seven days of 5 mg or 10 mg daily biotin. Some studied methods were affected, while another studied platform showed no interference under the conditions tested. The duration of the observed effect differed between the two doses and between methods. [6]

These experiments support planning around the actual supplement exposure and test method. They do not support a single stopping rule for every supplement user, laboratory, or blood test.

Thyroid tests: avoid changing treatment on an unexplained pattern

Biotin-related interference can make certain thyroid results resemble excess thyroid hormone. Thyroid care may also involve thyroglobulin testing after treatment for some thyroid cancers, where an inaccurately low measurement can matter. The American Thyroid Association highlights the need to recognize these measurement problems when interpreting thyroid blood work. [9]

If a result appears inconsistent with your symptoms or previous results, tell your clinician about the product and timing before drawing conclusions. Do not independently change levothyroxine or another prescribed medicine because you suspect biotin interference. The next step could involve checking the laboratory method, repeating a sample under planned conditions, or using a suitable alternative method.

There is also a distinction between “I feel well” and “the result must be wrong.” Symptoms are useful information, but some thyroid problems cause few symptoms. The purpose of raising biotin use is to improve interpretation, not to dismiss an abnormal result. An assessment should remain open to both a genuine thyroid problem and a measurement problem.

Troponin: disclosure must accompany urgent care

Troponin measurements help clinicians assess possible injury to heart muscle. The FDA has received reports of biotin interference producing falsely low troponin results with susceptible assays. Some manufacturers have improved their methods, but the FDA continues to identify concern with particular tests. [7]

A supplement history matters in emergency care because a misleadingly low result can provide false reassurance. Say that you take biotin, give the amount if known, and state when you last took it. If possible, show the label. Give this information while receiving care; locating a bottle or calculating a dose should not delay seeking help.

Emergency clinicians must decide how to investigate symptoms using the clinical picture and available testing. A person experiencing possible heart attack symptoms should not decide that a prior normal blood test makes a new episode safe, or arrange a private repeat test in place of emergency assessment.

Other tests and newer reagents: the method still matters

Biotin interference extends beyond thyroid testing. Laboratory research has examined susceptible tests measuring tumour markers, reproductive or other hormones, and selected nutritional markers. The significance depends on the specific assay rather than the category of test. In the JAMA study, even assays using biotin chemistry were not uniformly affected at the tested exposure. [4]

A 2025 laboratory study compared older and newer reagents for several tests and found improved biotin tolerance with the newer versions studied. It also examined patient samples and experimental samples with added biotin. This helps explain why an old online table or someone else’s experience may not describe the method currently used for you. [8]

Improved tolerance does not establish that all interference has disappeared. Results from spiked samples identify analytical vulnerability under controlled conditions; they do not directly measure how frequently a particular supplement causes a missed diagnosis in a Canadian clinic.

Dosage, forms, and realistic expectations

Pay attention to units. One milligram equals 1,000 micrograms. A product containing 5,000 micrograms supplies 5 mg; 10,000 micrograms supplies 10 mg. The adult adequate intake for biotin is 30 micrograms daily. Biotin appears in individual supplements, B-complex products, and multivitamins, so consider the total from different bottles. [2]

These figures describe nutritional context and research exposures. They are not a recommended dose for you and do not define a boundary below which every assay is guaranteed to be unaffected. A serving can include more than one tablet or gummy; record the amount you actually take rather than the largest number on the front label.

A capsule, gummy, liquid, or product advertised for beauty should all be included in the history when they contain biotin. The relevant information is the ingredient, quantity, frequency, and timing. The product’s marketing category does not answer the laboratory question.

For someone taking biotin for hair concerns without an established indication, a useful clinician discussion is whether the expected benefit justifies continued use and additional testing precautions. People prescribed biotin for a medical condition need a coordinated plan rather than an unsupervised interruption.

How long before a blood test should biotin be held?

There is no single interval that this article can safely apply to every reader. The AACC guidance describes assay-specific management and notes that biotin clearance and the concentration needed to interfere vary. Kidney impairment and very high exposure can complicate planning. [3]

Thyroid-focused patient guidance and controlled thyroid studies provide different preparation intervals in their particular settings. That variation is a reason to obtain instructions for your own test, rather than choose the shortest interval found online. [6] [9]

The FDA’s device guidance recommends testing interference near clinical decision points and communicating relevant susceptibility to laboratories and clinicians. A preparation plan should therefore connect your exposure to the laboratory’s current method. [10]

For a planned appointment, ask the ordering clinician or laboratory for instructions before the collection date. If they recommend a hold, ask which product, when to take the last dose, and when to restart. Confirm how the plan applies to a medically necessary product. For urgent testing, report the exposure promptly and let the treating team manage the testing strategy.

Iron and vitamin B12: a different testing conversation

Iron treatment and ferritin interpretation

Iron treatment can change genuine iron status and blood counts over time. That is different from biotin disrupting an assay. British Columbia’s iron-deficiency guideline identifies ferritin as a central test for iron deficiency and emphasizes investigating the cause. It also warns that inflammation and chronic disease can make ferritin less reliable as a reflection of iron stores. [11]

A higher ferritin result does not automatically establish either successful treatment or iron overload. Ask which question the test is intended to answer: diagnosis, response to treatment, or investigation of an unexpected finding. Share when treatment started, the product, and any prescribed dosing changes.

Do not apply a biotin stopping interval to iron. Follow preparation instructions for the particular tests ordered. Nor should a person begin iron solely to improve a laboratory number without understanding why it is abnormal.

B12 supplements can make the untreated baseline harder to assess

NICE’s guideline recommends obtaining diagnostic blood samples before starting vitamin B12 replacement when possible and asking about existing over-the-counter B12 use. It cautions that supplements may increase measured total or active B12 without fully treating a deficiency. It also says not to delay replacement while awaiting results in people with suspected megaloblastic anaemia and neurological symptoms. This is UK guidance, used here to explain testing principles rather than Canadian service rules. [12]

If you have already started B12, give your clinician the start date, dose, route, and reason. Do not attempt to recreate a deficiency by stopping necessary treatment. A clinician may need to interpret the available results alongside symptoms, the cause of possible deficiency, and other appropriate investigations.

Vitamin B12 supports red blood cells and nerve function. Its absorption depends on digestive processes; metformin and acid-suppressing medicines can contribute to low B12 in some people. Additional markers such as methylmalonic acid can help in selected cases, but kidney impairment can raise that marker too. A second test is therefore not an automatic answer independent of clinical context. [13]

Safety, side effects, interactions, and contraindications

A supplement can cause harm through a misleading test even if it does not cause obvious symptoms after each dose. That makes “I tolerate it well” an incomplete safety assessment. Biotin also has a medication context: prolonged use of some antiseizure medicines can affect biotin status. Review the full medication list with a clinician; do not adjust seizure treatment yourself. [2]

Iron supplements can cause gastrointestinal effects such as nausea or constipation, and excessive intake can be dangerous, especially for children. Iron can also reduce absorption of levothyroxine and levodopa. People with iron overload should not self-prescribe iron. A pharmacist can check the product and medication schedule, including separation instructions appropriate to the prescribed medicine. [14]

This interaction illustrates a physiological pathway to a changed result: reduced absorption of a prescribed medicine can alter its effect. That problem requires a medication review, rather than assuming that the laboratory instrument is wrong.

Seek individual advice before adding or changing supplements during pregnancy or breastfeeding, for a child, with kidney disease, or while receiving specialist treatment. These circumstances do not make every supplement unsuitable, but they do make a generic online plan inadequate. Include combination products: other ingredients can introduce risks unrelated to biotin. [15]

A practical preparation plan for Canadian patients

Health Canada recommends that patients know the contents of their supplements, discuss biotin exposure with their doctor, and raise concerns about test results. It also asks clinicians to inform the laboratory when high biotin intake is relevant and laboratories to follow the manufacturer’s instructions. [1]

For natural health products sold in Canada, look for an eight-digit Natural Product Number, or NPN, and check the authorized product information and warnings. An authorization does not establish that a product is appropriate for your circumstances or compatible with every test. Health Canada emphasizes discussing natural health products with health professionals and recognizing possible interactions. [15]

A short written record is often more useful than a vague statement that you take vitamins. Prepare it before the appointment:

  1. Identify every product. Record the brand and exact product name. Include prescribed supplements, over-the-counter products, powders, gummies, and products taken only occasionally.
  2. Copy the ingredients and amounts. Note units and serving size. If you take two servings, write that explicitly. Bring the label or a readable photograph of it.
  3. Record your actual use. State when you started, how often you take it, and the date and time of the most recent dose. If the time is uncertain, say so.
  4. State the purpose. Explain whether a clinician prescribed it, you started it yourself, or the indication is unclear. This helps distinguish optional use from necessary treatment.
  5. Clarify preparation. Ask for the specific collection instructions, including any product hold and any fasting requirement. Do not assume that fasting instructions answer the biotin question.
  6. Close the loop. Ask who will review the result and who to contact if the instructions are unclear or if you accidentally take a product during an agreed hold.

Keep this record with your medication list so it is available when a different clinician orders a test. Update it when a product changes; a similarly named replacement may have a different formulation.

Questions that make the clinician discussion more useful

You do not need to diagnose interference yourself. Aim to give the care team the information needed to evaluate it. Useful questions include:

  • What clinical question will this test answer, and would an inaccurate result change treatment?
  • Does my product contain biotin, and does the laboratory need its dose and timing recorded?
  • Has the laboratory confirmed whether the requested method is susceptible?
  • If preparation is needed, can I have instructions for this product and this collection?
  • If a result conflicts with other findings, how will the team distinguish interference from a real change?
  • Am I taking this supplement for a documented indication, and when should its continued use be reviewed?

If you receive a surprising report through an online portal, send a concise message naming the result, the product, and the timing. Avoid changing several products or medicines at once while waiting for advice; doing so makes the sequence harder to interpret. Follow urgent instructions given by your care team.

Frequently asked questions

Does biotin interfere with every blood test?

No. Susceptibility depends on the method. The controlled human study found interference in some biotin-based assays and none of its non-biotin comparison assays under the tested conditions. That result cannot guarantee the behaviour of every current test. [4]

Does taking biotin mean I have a thyroid disorder?

No. Biotin exposure can make a susceptible test misleading; it does not establish a diagnosis. Tell the clinician about it and let them evaluate the test together with your history and symptoms. [9]

Should I stop all supplements before blood work?

Obtain instructions for the specific test and products. A blanket interruption can be inappropriate, particularly for prescribed replacement. Supplements should not replace prescribed treatment. Bring your supplement list and clarify preparation in advance rather than guessing.

What if I forgot and took my biotin?

Tell the clinician or laboratory the amount and time. They can decide whether to proceed, modify testing, or reschedule a non-urgent collection. Do not conceal the dose or assume the entire sample is unusable.

Can newer laboratory methods solve the problem?

Some newer reagents have improved resistance, but the evidence remains method-specific. Your laboratory needs to assess its current test; a brand name or old interference table is insufficient. [8]

Do I need to avoid normal biotin-containing foods?

Health Canada says the approximately 30 micrograms used as the adult nutritional reference does not generally cause interference. This article does not recommend restricting ordinary foods. Discuss supplemental exposure and follow any separate preparation instructions. [1]

Does feeling well mean a supplement cannot affect my tests?

No. A measurement problem may occur without noticeable side effects from the supplement. Tell the laboratory and clinician what you take even if you feel well. The absence of symptoms does not establish the accuracy of a susceptible assay.

What if I take biotin and develop chest pain?

Seek emergency care immediately and disclose biotin use. Possible interference is a reason to inform the team, never a reason to postpone assessment until a washout period has elapsed. [7]

References

  1. Health Canada. Biotin and the risk of false lab test results. Updated January 10, 2025.
  2. NIH Office of Dietary Supplements. Biotin: Fact Sheet for Health Professionals.
  3. Li D, et al. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med. 2020;5:575–587.
  4. Li D, et al. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults. JAMA. 2017;318:1150–1160.
  5. Ylli D, et al. Biotin Interference in Assays for Thyroid Hormones, Thyrotropin and Thyroglobulin. Thyroid. 2021;31:1160–1170.
  6. Zhang Y, et al. Assessment of biotin interference in thyroid function tests. Medicine. 2020;99:e19232.
  7. US Food and Drug Administration. Biotin Interference with Troponin Lab Tests: Assays Subject to Biotin Interference.
  8. Chiu KC, et al. Biotin interference in routine clinical immunoassays. Pract Lab Med. 2025;45:e00472.
  9. American Thyroid Association. Biotin use can interfere with the management of thyroid diseases, including thyroid cancer. Clinical Thyroidology for the Public. January 2022.
  10. US Food and Drug Administration. Testing for Biotin Interference in In Vitro Diagnostic Devices. Guidance for Industry. October 2020.
  11. Province of British Columbia. Iron Deficiency: Diagnosis and Management. BC Guidelines. 2019.
  12. National Institute for Health and Care Excellence. Vitamin B12 deficiency in over 16s: diagnosis and management. NG239. Recommendations.
  13. NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals.
  14. NIH Office of Dietary Supplements. Iron: Fact Sheet for Health Professionals.
  15. Health Canada. About Natural Health Products.

Medical disclaimer

This article provides general educational information and is not a substitute for personalized medical advice, diagnosis, or treatment. It is not a laboratory preparation order. Test methods, product formulations, and clinical circumstances differ. Discuss supplement use and testing instructions with your qualified clinician, pharmacist, and laboratory. Do not change prescribed medicines or medically necessary supplements without professional guidance. For possible heart attack symptoms, call 911 in Canada or seek emergency care immediately. Disclose biotin use without delaying care.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top